The National Healthcare Security Administration's special campaign continues to crack down on illegal chains of "reflowed drugs."

On April 2nd, the National Healthcare Security Administration learned that the Office of the National Healthcare Security Administration recently issued the “Notice on Deepening Special Actions to Combat Illegal and Violating Activities in the Field of Medical Insurance Drugs,” clarifying that starting from April 2026, with drug traceability code suspicious clues as the focus, a continued in-depth crackdown on illegal and irregular activities in the field of medical insurance drugs will be carried out nationwide.
It is reported that the special action is divided into two phases: the first phase from April to July 2026, and the second phase from September to November 2026. The National Healthcare Security Administration will issue a batch of suspicious clues regarding duplicate settlement of drug traceability codes in early April and early September 2026.
Local healthcare security departments, in coordination with relevant departments, will coordinate clues issued by the state, local over-prescription clues, and public reports and complaints, to conduct in-depth investigations and rectifications, precisely target illegal activities such as reselling “reflow drugs” covered by medical insurance, swapping medical insurance drugs, falsifying or fabricating medical insurance vouchers, forging prescriptions, illicit drug purchases, and year-end consumption surges, and promptly recover losses to the medical insurance fund. (Xinhua News Agency)